{"lastUpdatedAt": 1611080740240, "totalPosts": {"label": "Total Posts", "value": 65}, "totalComments": {"label": "Total Comments", "value": 185}, "postRate": {"title": "Post Rate", "data": [{"label": "2021-01-18T01:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T02:00:00.000+05:30", "value": 6}, {"label": "2021-01-18T03:00:00.000+05:30", "value": 3}, {"label": "2021-01-18T04:00:00.000+05:30", "value": 3}, {"label": "2021-01-18T06:00:00.000+05:30", "value": 2}, {"label": "2021-01-18T07:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T08:00:00.000+05:30", "value": 2}, {"label": "2021-01-18T09:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T10:00:00.000+05:30", "value": 2}, {"label": "2021-01-18T11:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T13:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T14:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T17:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T18:00:00.000+05:30", "value": 2}, {"label": "2021-01-18T19:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T20:00:00.000+05:30", "value": 3}, {"label": "2021-01-18T21:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T22:00:00.000+05:30", "value": 4}, {"label": "2021-01-18T23:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T00:00:00.000+05:30", "value": 6}, {"label": "2021-01-19T01:00:00.000+05:30", "value": 1}, {"label": "2021-01-19T02:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T03:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T04:00:00.000+05:30", "value": 4}, {"label": "2021-01-19T06:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T07:00:00.000+05:30", "value": 3}, {"label": "2021-01-19T08:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T09:00:00.000+05:30", "value": 3}, {"label": "2021-01-19T10:00:00.000+05:30", "value": 1}, {"label": "2021-01-19T12:00:00.000+05:30", "value": 1}]}, "commentRate": {"title": "Comment Rate", "data": [{"label": "2021-01-19T23:00:00.000+05:30", "value": 185}]}, "commentSentiments": {"title": "Comment Sentiments", "data": [{"name": "neutral", "value": 84}, {"name": "positive", "value": 73}, {"name": "negative", "value": 28}]}, "postSentiments": {"title": "Post Sentiments", "data": [{"name": "neutral", "value": 38}, {"name": "positive", "value": 22}, {"name": "negative", "value": 5}]}, "topStocks": {"title": "Top stocks", "data": [{"label": "LPCN", "value": 1}, {"label": "FRSX", "value": 1}, {"label": "EAST", "value": 1}, {"label": "DGLY", "value": 1}, {"label": "ACRS", "value": 1}, {"label": "TRCH", "value": 2}, {"label": "TANH", "value": 2}, {"label": "BNGO", "value": 2}, {"label": "ZYXI", "value": 61}]}, "stockRatings": {"title": "Stock Ratings", "data": {"LPCN": {"score": {"P/B": 5, "ROA": 2, "DCF": 4, "P/E": 3, "ROE": 2, "D/E": 4}, "recommendation": {"P/B": "Strong Buy", "ROA": "Buy", "DCF": "Buy", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "FRSX": {"score": {"P/B": 5, "ROA": 2, "DCF": 4, "P/E": 3, "ROE": 2, "D/E": 4}, "recommendation": {"P/B": "Strong Buy", "ROA": "Buy", "DCF": "Buy", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "EAST": {"score": {"P/B": 5, "ROA": 2, "DCF": 5, "P/E": 3, "ROE": 2, "D/E": 5}, "recommendation": {"P/B": "Strong Buy", "ROA": "Strong Buy", "DCF": "Strong Buy", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "DGLY": {"score": {"P/B": 3, "ROA": 2, "DCF": 3, "P/E": 3, "ROE": 5, "D/E": 3}, "recommendation": {"P/B": "Neutral", "ROA": "Neutral", "DCF": "Neutral", "P/E": "Neutral", "ROE": "Strong Buy", "D/E": "Sell"}}, "ACRS": {"score": {"P/B": 5, "ROA": 2, "DCF": 5, "P/E": 3, "ROE": 2, "D/E": 5}, "recommendation": {"P/B": "Strong Buy", "ROA": "Strong Buy", "DCF": "Strong Buy", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "TRCH": {"score": {"P/B": 5, "ROA": 2, "DCF": 5, "P/E": 3, "ROE": 2, "D/E": 5}, "recommendation": {"P/B": "Strong Buy", "ROA": "Strong Buy", "DCF": "Strong Buy", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "TANH": {"score": {"P/B": 5, "ROA": 3, "DCF": 5, "P/E": 5, "ROE": 3, "D/E": 5}, "recommendation": {"P/B": "Strong Buy", "ROA": "Strong Buy", "DCF": "Strong Buy", "P/E": "Strong Buy", "ROE": "Neutral", "D/E": "Neutral"}}, "BNGO": {}, "ZYXI": {}}}, "enterprise": {"title": "Enterprise History", "data": {"LPCN": {"symbol": "LPCN", "stockPrice": 0.454, "numberOfShares": 25882273, "marketCapitalization": 11750551.942, "minusCashAndCashEquivalents": 9728523.0, "addTotalDebt": 8154448.0, "enterpriseValue": 10176476.942}, "FRSX": {}, "EAST": {"symbol": "EAST", "stockPrice": 3.75, "numberOfShares": 9275696.0, "marketCapitalization": 34783860, "minusCashAndCashEquivalents": 343293.0, "addTotalDebt": 6555820.0, "enterpriseValue": 40996387}, "DGLY": {"symbol": "DGLY", "stockPrice": 0.97, "numberOfShares": 11478618, "marketCapitalization": 11134259.459999999, "minusCashAndCashEquivalents": 359685, "addTotalDebt": 6500000, "enterpriseValue": 17274574.46}, "ACRS": {"symbol": "ACRS", "stockPrice": 1.32, "numberOfShares": 41323921, "marketCapitalization": 54547575.720000006, "minusCashAndCashEquivalents": 35937000, "addTotalDebt": 39078000, "enterpriseValue": 57688575.720000006}, "TRCH": {"symbol": "TRCH", "stockPrice": 0.62, "numberOfShares": 72857079, "marketCapitalization": 45171388.98, "minusCashAndCashEquivalents": 89730.0, "addTotalDebt": 11871934, "enterpriseValue": 56953592.98}, "TANH": {"symbol": "TANH", "stockPrice": 1.43, "numberOfShares": 28853240, "marketCapitalization": 41260133.199999996, "minusCashAndCashEquivalents": 12440460, "addTotalDebt": 7353930.0, "enterpriseValue": 36173603.199999996}, "BNGO": {"symbol": "BNGO", "stockPrice": 1.09, "numberOfShares": 34274469, "marketCapitalization": 37359171.21, "minusCashAndCashEquivalents": 17311373, "addTotalDebt": 0.0, "enterpriseValue": 20047798.21}, "ZYXI": {"symbol": "ZYXI", "stockPrice": 9.73, "numberOfShares": 32439000, "marketCapitalization": 315631470, "minusCashAndCashEquivalents": 14040000, "addTotalDebt": 0.0, "enterpriseValue": 301591470}}}, "profile": {"title": "Company Profile", "data": {"LPCN": {"symbol": "LPCN", "price": 1.97, "beta": 0.49783, "volAvg": 2462270, "mktCap": 129401816, "lastDiv": 0.0, "range": "0.301-2.39", "changes": 0.35, "companyName": "Lipocine Inc", "currency": "USD", "cik": "0001535955", "isin": "US53630X1046", "cusip": "53630X104", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Biotechnology", "website": "https://www.lipocine.com/", "description": "Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. Its primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The company has a portfolio of product candidates designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1111, an oral testosterone therapy product for once daily dosing that completed Phase 2b testing; LPCN 1148, an oral prodrug of bioidentical testosterone for the treatment of non-alcoholic steatohepatitis cirrhosis (NASH); LPCN 1107, an oral hydroxyprogesterone caproate product for the prevention of recurrent preterm birth; and LPCN 1144, an oral prodrug of bioidentical testosterone that is in Phase 2 Clinical trial for the treatment of NASH. Lipocine Inc. is headquartered in Salt Lake City, Utah.", "ceo": "Dr. Mahesh Patel", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "12", "phone": "18019947383", "address": "675 S Arapeen Dr Ste 202", "city": "Salt Lake City", "state": "UTAH", "zip": "84108", "dcfDiff": null, "dcf": 1.70588, "image": "https://financialmodelingprep.com/image-stock/LPCN.jpg", "ipoDate": "2014-03-21", "defaultImage": true}, "FRSX": {"symbol": "FRSX", "price": 9.8502, "beta": 1.489432, "volAvg": 11597256, "mktCap": 448892320, "lastDiv": 0.0, "range": "0.461-10.88", "changes": 2.0302, "companyName": "Foresight Autonomous Holdings Ltd.", "currency": "USD", "cik": null, "isin": null, "cusip": null, "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Auto Parts", "website": "http://www.foresightauto.com", "description": null, "ceo": "Mr. Haim Siboni", "sector": "Consumer Cyclical", "country": "Israel", "fullTimeEmployees": "61", "phone": "972 7 770 9030", "address": "Weizmann Science Park", "city": "Ness Ziona", "state": null, "zip": "7403650", "dcfDiff": -1.26, "dcf": 0.0, "image": "https://financialmodelingprep.com/image-stock/FRSX.jpg", "ipoDate": null, "defaultImage": true}, "EAST": {"symbol": "EAST", "price": 1.465, "beta": 1.75545, "volAvg": 173791, "mktCap": 14868725, "lastDiv": 0.0, "range": "0.92-3.75", "changes": 0.085, "companyName": "Eastside Distilling Inc", "currency": "USD", "cik": "0001534708", "isin": "US2778023026", "cusip": "277802302", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Beverages Wineries & Distilleries", "website": "https://www.eastsidedistilling.com/", "description": "Eastside Distilling, Inc. engages in the manufacture and marketing of hand-crafted spirits. The company is headquartered in Portland, Oregon and currently employs 5 full-time employees. The firm's beverage alcohol categories include bourbon, whiskey, rum and vodka. The firm operates through the marketing and distributing of hand-crafted spirits segment. Its brands include Burnside Bourbon, Burnside Oregon Oaked Bourbon, Barrel Hitch American Whiskey, Barrel Hitch Oregon Oak American Whiskey, Below Deck Silver Rum, Below Deck Ginger Rum, Below Deck Coffee Rum, Below Deck Spiced Rum, Portland Potato Vodka, Marionberry Whiskey and Cherry Bomb Whiskey. Eastside creates seasonal and limited edition handmade products, such as Advocaat (eggnog) Liqueur, Peppermint Bark Liqueur, Bier Schnapps and Holiday Spiced Liqueur. Eastside distributes its products in approximately 15 states, including Oregon, Washington, Nevada, Texas, Virginia, Indiana, Illinois, New York, New Jersey, Massachusetts, Connecticut, Minnesota, Georgia, Pennsylvania and Maryland.", "ceo": "Mr. Lawrence Firestone", "sector": "Consumer Defensive", "country": "US", "fullTimeEmployees": "82", "phone": "19718884264", "address": "1001 SE Water Ave Ste 390", "city": "Portland", "state": "OREGON", "zip": "97214", "dcfDiff": -5.72, "dcf": 1.35701, "image": "https://financialmodelingprep.com/image-stock/EAST.png", "ipoDate": "2013-07-22", "defaultImage": false}, "DGLY": {"symbol": "DGLY", "price": 2.9633, "beta": 0.62727, "volAvg": 6486443, "mktCap": 79335544, "lastDiv": 0.0, "range": "0.64-7.1", "changes": -0.0867, "companyName": "Digital Ally Inc", "currency": "USD", "cik": "0001342958", "isin": "US25382P2083", "cusip": "25382P208", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Security & Protection Services", "website": "http://www.digitalallyinc.com/", "description": "Digital Ally, Inc. produces and sells digital video imaging and storage products for use in law enforcement, security, and commercial applications in the United States and internationally. Its digital audio/video recording, storage, and other products include an in-car digital audio/video recorder that is contained in a rear view mirror for law enforcement vehicles and commercial fleets; and hands-free automatic activated body-worn cameras and in-car video systems, as well as provides its law enforcement customers with audio/video surveillance from multiple vantage points. The company also provides VuLink, an in-car device that enables an in-car and body worn digital audio/video camera system to automatically and simultaneously start recording; and Digital Ally, a suite of data management Web-based tools to assist fleet managers in the organization, archival, and management of videos and telematics information. In addition, its digital audio/video recording, storage, and other products comprise a miniature body-worn digital video system; VuVault.net, a law enforcement cloud storage solution, including cloud-based fleet management and driver monitoring/training applications; and FleetVU Manager, a Web-based software for commercial fleet tracking and monitoring. The company sells its products through direct sales and third-party distributors. Digital Ally, Inc. is headquartered in Lenexa, Kansas.", "ceo": "Mr. Stanton Ross", "sector": "Industrials", "country": "US", "fullTimeEmployees": "119", "phone": "19132325349", "address": "9705 Loiret Blvd", "city": "Lenexa", "state": "KANSAS", "zip": "66219", "dcfDiff": -8.43, "dcf": 2.16134, "image": "https://financialmodelingprep.com/image-stock/DGLY.png", "ipoDate": "2005-02-22", "defaultImage": false}, "ACRS": {"symbol": "ACRS", "price": 16.35, "beta": 1.45233, "volAvg": 589506, "mktCap": 701730560, "lastDiv": 0.0, "range": "0.7-19.74", "changes": 10.47, "companyName": "Aclaris Therapeutics Inc", "currency": "USD", "cik": "0001557746", "isin": "US00461U1051", "cusip": "00461U105", "exchange": "Nasdaq Global Select", "exchangeShortName": "NASDAQ", "industry": "Biotechnology", "website": "https://www.aclaristx.com/", "description": "Aclaris Therapeutics, Inc., a biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. It operates in two segments, Therapeutics and Contract Research. The company offers ESKATA, a formulation of high-concentration hydrogen peroxide topical solution for raised seborrheic keratosis, a common non-malignant skin tumor. It is also developing A-101, a high-concentration formulation of hydrogen peroxide that is in Phase III clinical trial for common warts; and ATI-501 and ATI-502 Janus kinase (JAK) inhibitors, which are in Phase II clinical trials for alopecia areata (AA) and other dermatological indications. In addition, the company's products under development include ATI-450 an investigational oral, novel, small molecule selective MK2 inhibitor compound for the treatment of rheumatoid arthritis; ATI-1777 soft inhibitor for atopic dermatitis; and ATI-2138, an investigational oral ITK/TXK/JAK3, or ITJ, inhibitor compound, for the treatment of psoriasis inflammatory bowel disease. Further, it provides contract research services. Aclaris Therapeutics, Inc. has a license and collaboration agreement with Rigel Pharmaceuticals, Inc. for the development and commercialization of JAK inhibitors. The company was founded in 2012 and is headquartered in Wayne, Pennsylvania.", "ceo": "Dr. Neal Walker", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "75", "phone": "14843247933", "address": "640 Lee Rd Ste 200", "city": "Wayne", "state": "PENNSYLVANIA", "zip": "19087", "dcfDiff": -6.4, "dcf": 5.11964, "image": "https://financialmodelingprep.com/image-stock/ACRS.png", "ipoDate": "2015-10-07", "defaultImage": false}, "TRCH": {"symbol": "TRCH", "price": 1.52, "beta": 2.41048, "volAvg": 5581227, "mktCap": 151454624, "lastDiv": 0.0, "range": "0.21-1.58", "changes": 0.15, "companyName": "Torchlight Energy Resources Inc", "currency": "USD", "cik": "0001431959", "isin": "US89102U1034", "cusip": "89102U103", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Oil & Gas E&P", "website": "https://www.torchlightenergy.com/", "description": "Torchlight Energy Resources, Inc. engages in the acquisition, exploration, exploitation and development of oil and natural gas properties in the United States. The company is headquartered in Plano, Texas and currently employs 2 full-time employees. The firm focuses on drilling and working interest programs within the United States. The firm has interests in approximately four oil and gas projects: the Marcelina Creek Field Development in Wilson County, Texas; the Ring Energy Joint Venture in Southwest Kansas; Hunton wells in partnership with Husky Ventures in Central Oklahoma, and the Orogrande Project in Hudspeth County, Texas. The firm also operates through two other subsidiaries, including Torchlight Energy Operating, LLC, a Texas limited liability company, and Hudspeth Oil Corporation, a Texas corporation. The Marcelina Creek Field Development is located over the Austin Chalk, Buda and Eagle Ford Formations.", "ceo": "Mr. John Brda", "sector": "Energy", "country": "US", "fullTimeEmployees": "4", "phone": "12144328002", "address": "5700 W Plano Pkwy Ste 3600", "city": "Plano", "state": "TEXAS", "zip": "75093", "dcfDiff": null, "dcf": 0.0, "image": "https://financialmodelingprep.com/image-stock/TRCH.png", "ipoDate": "2009-10-27", "defaultImage": false}, "TANH": {"symbol": "TANH", "price": 1.89, "beta": 0.35426, "volAvg": 4317580, "mktCap": 67839848, "lastDiv": 0.0, "range": "0.81-3.65", "changes": 0.08, "companyName": "Tantech Holdings Ltd", "currency": "USD", "cik": "0001588084", "isin": "VGG8675X1078", "cusip": "G8675X107", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Coal", "website": "http://www.tantech.cn", "description": "Tantech Holdings Ltd. engages in the development and manufacture of bamboo-based charcoal products. The company is headquartered in Lishui, Zhejiang and currently employs 99 full-time employees. The Company, through its subsidiaries, is a developer and manufacturer of bamboo-based charcoal products for industrial energy applications and household cooking, heating, purification, agricultural and cleaning uses. The firm has three segments: consumer product, trading and biofuel energy. The Consumer products segment manufactures and sells Charcoal Doctor branded products and barbecue (BBQ) charcoal in China. Its products include purification and deodorization products and cleaning products. The Trading segment conducts rubber and other trading businesses. The firm's subsidiary, Tantech Charcoal, is engaged in the trading business. The biofuel energy segment produces and sells BBQ charcoal to customers in Asia, Europe and North America. The company produces and sells bamboo-based fuel for Electric Double-Layer Capacitor (EDLC). Tantech BVI's solid charcoal products are used for purification and deodorization.", "ceo": " Zhengyu Wang", "sector": "Basic Materials", "country": "CN", "fullTimeEmployees": "71", "phone": "865782262309", "address": "No. 10 Cen Shan Rd, Shuige Indtrl Zone, Lishul City", "city": "Lishui", "state": "ZHEJIANG", "zip": null, "dcfDiff": -1.4, "dcf": 2.95335, "image": "https://financialmodelingprep.com/image-stock/TANH.jpg", "ipoDate": "2015-03-24", "defaultImage": true}, "BNGO": {"symbol": "BNGO", "price": 9.14, "beta": 0.0, "volAvg": 63079645, "mktCap": 2079185540, "lastDiv": 0.0, "range": "0.25-9.95", "changes": 0.71, "companyName": "Bionano Genomics Inc", "currency": "USD", "cik": "0001411690", "isin": "US09075F1075", "cusip": "09075F107", "exchange": "NasdaqCM", "exchangeShortName": "NASDAQ", "industry": "Diagnostics & Research", "website": "https://bionanogenomics.com/", "description": "BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The company is headquartered in San Diego, California and currently employs 77 full-time employees. The firm develops and markets the Saphyr system. The Company\u2019s products include Sequencing for Discovery Research and Cytogenetics. Sequencing alone, however, is significantly limited due to its inability to reveal structural variations. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response.", "ceo": "DR. R. Erik Holmlin", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "97", "phone": "18588887600", "address": "9540 Towne Centre Dr Ste 100", "city": "San Diego", "state": "CALIFORNIA", "zip": "92121", "dcfDiff": null, "dcf": null, "image": "https://financialmodelingprep.com/image-stock/BNGO.png", "ipoDate": "2018-08-01", "defaultImage": false}, "ZYXI": {"symbol": "ZYXI", "price": 17.9, "beta": 0.67852, "volAvg": 533546, "mktCap": 622687300, "lastDiv": 0.0, "range": "7.93-29.73", "changes": 1.38, "companyName": "Zynex Inc", "currency": "USD", "cik": "0000846475", "isin": "US98986M1036", "cusip": "98986M103", "exchange": "NasdaqCM", "exchangeShortName": "NASDAQ", "industry": "Medical Devices", "website": "https://www.zynex.com/", "description": "Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also supplies electrodes for the delivery of electrical current to the body and batteries for use in electrotherapy products; and distributes Comfortrac for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.", "ceo": "Mr. Thomas Sandgaard", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "283", "phone": "13038673904", "address": "9555 MAROON CIRCLE", "city": "Englewood", "state": "COLORADO", "zip": "80112", "dcfDiff": null, "dcf": 14.1834, "image": "https://financialmodelingprep.com/image-stock/ZYXI.jpg", "ipoDate": "2002-11-27", "defaultImage": true}}}, "news": ["https://www.fool.com/investing/2021/01/19/why-aclaris-therapeutics-stock-skyrocketed-more-th/", "https://www.marketwatch.com/story/aclaris-therapeutics-stock-more-than-triples-after-positive-data-on-arthritis-treatment-trial-2021-01-19", "https://investorplace.com/2021/01/acrs-stock-alert-why-aclaris-therapeutics-is-up-over-200-today/", "https://www.benzinga.com/general/biotech/21/01/19214235/why-aclaris-tenax-gritstone-merus-minerva-and-celyad-are-rallying-today", "https://247wallst.com/healthcare-business/2021/01/19/is-aclaris-therapeutics-a-stock-to-buy-after-nearly-200-run-up-and-now-this/"]}